Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Novel anti-EGFR antibody-drug conjugate AVID100: A phase 2a trial in patients with EGFR-overexpressing advanced solid tumors Melear, J., Lakhani, N., O'Shaughnessy, J. A., Wilks, S. T., Khan, S., Chandana, S. R., Tolcher, A. W., Papadopoulos, K. P., Cole, Y., Rivas, K., Ghosh, R., Sinclair, S., Lutz, R., Nadler, P. I., Wood, D. L., Burtness, B. AMER ASSOC CANCER RESEARCH. 2019
View details for DOI 10.1158/1535-7163.TARG-19-A088
View details for Web of Science ID 000510047200076